JeffreyThomasJensenMD
Obstetrics & Gynecology • Portland, ORProfessor, Obstetrics & Gynecology, Oregon Health and Science University School of Medicine
Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Dept Ob/Gyn, Uhn-70, Ohsu
Portland, OR 97239Phone+1 503-494-4469Fax+1 503-494-5083
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Obstetrics and Gynecology, 1985 - 1988
Santa Clara Valley Medical CenterInternship, Transitional Year, 1984 - 1985
Emory University School of MedicineClass of 1984
Certifications & Licensure
OR State Medical License 1985 - 2025
WA State Medical License 2023 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- A Study of Continuous Oral Contraceptives and Doxycycline Start of enrollment: 2007 May 01
- Hormonal Contraception and Vaginal Health Start of enrollment: 2007 May 01
- Relationship Between the Menstrual Cycle and Heart Disease in Women Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Effects of estetrol/drospirenone on Self-Reported Physical and Emotional Premenstrual and Menstrual Symptoms: Data from the Phase 3 Clinical Trial in the United States...Céline Bouchard, Johannes Bitzer, Melissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz
Contraception. 2025-03-20 - 1 citationsUse of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter c...Jeffrey T Jensen, Alison Edelman, Carolyn L Westhoff, Coutney A Schreiber, David F Archer
Contraception. 2024-09-01 - 4 citationsEmergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.Alison Edelman, Jeffrey T Jensen, Jill Brown, Michael Thomas, David F Archer
Contraception. 2024-09-01
Press Mentions
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy DesignationOctober 24th, 2024
Bayer's Removal of Contraceptive Device Essure Praised by ActivistsJuly 27th, 2018
Grant Support
- A low-profile copper intrauterine device that delivers long-acting contraception anUNIVERSITY OF WASHINGTON2020–2025
- Transcervical Polidocanol Foam As Nonsurgical Female Sterilization TechniqueNational Center For Research Resources2011
- Phosphodiesterase 3 Inhibitors: Blockers Of Oocyte Maturation And FertilizationNational Center For Research Resources2007–2011
- PDE3 Inhibitors: Selective Blockers Of Oocyte MaturationEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2007
- Phosphodiesterase 3 Inhibitors: Selective Blockers Of Oocyte Maturation And FertNational Center For Research Resources2005–2006
- Transcervical Polidocanol As A Non-Surgical Method Of Female SterilizationNational Center For Research Resources2004
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
